December 14, 2020
2 min watch
Save
VIDEO: Duration between diagnosis, treatment completion matters in breast cancer
You've successfully added to your alerts. You will receive an email when new content is published.
Click Here to Manage Email Alerts
Click Here to Manage Email Alerts
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.
To optimize outcomes for patients with breast cancer, efforts should focus on improving multimodality treatment options and reducing delays to treatment, according to Debra Pratt, MD.
Pratt and colleagues investigated an association between overall survival and the duration from diagnosis to completion of chemotherapy, surgery and radiation. The retrospective findings, presented at SABCS 2020, suggested that a week or longer delay in the completion of all three treatment modalities may worsen survival outcomes.
“We need to be efficient with our care for breast cancer patients,” Pratt advised.
Published by:
Sources/Disclosures
Collapse
Source:
Pratt D, et al. Abstract PS11-34. Presented at: San Antonio Breast Cancer Symposium (Virtual); Dec. 8-11, 2020.
Pratt D, et al. Abstract PS11-34. Presented at: San Antonio Breast Cancer Symposium (Virtual); Dec. 8-11, 2020.
Disclosures:
Pratt reports no relevant financial disclosures.
Read more about
You've successfully added to your alerts. You will receive an email when new content is published.
Click Here to Manage Email Alerts
Click Here to Manage Email Alerts
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.